Biocompatibility evaluation of dura mater substitutes in an animal model

被引:61
作者
Barbolt, TA
Odin, M
Léger, M
Kangas, L
Holste, J
Liu, SH
机构
[1] Ethicon Inc, Div Res & Dev, Somerville, NJ USA
[2] Merck Chibret, Riom, France
[3] ClinTrials BioRes Ltd, Senneville, PQ, Canada
[4] Ethicon GmbH, Norderstedt, Germany
关键词
dura mater substitute; neurologic; absorbable; tissue reaction; animal model;
D O I
10.1179/016164101101199405
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dura-Guard (R) Dural Repair Patch, PRECLUDE (R) Dura Substitute, and Codman (R) ETHISORB (TM) Dura Patch were evaluated in a six-month dural tissue reaction study in rabbits. Bilateral craniotomy was followed by subdural implantation for each dura mater substitute. The surgical procedure for the sham control group was the same except that no material was implanted. Implantation of all of these dura mater substitutes for 28, 91, or 182 days post-implantation did not result in any deaths or clinical neurobehavioral abnormalities, changes in cerebrospinal fluid, or significant macroscopic changes at necropsy. However, histomorphologic evaluation of the implantation sites revealed some differences in the tissue response to these materials. For Dura-Guard Dural Repair Patch, a nonabsorbable material derived from bovine pericardium, the implantation site was characterized by fibrosis of the overlying area with islands of osseous metaplasia and adhesions to the brain surface. Over time, infiltrative fibrosis of the implant resulted in separation of the collagenous layers of the implant and compression of the underlying brain. Fibrosis of the overlying area that incorporated this material formed a 'replacement' dura mater. Adhesions to the brain surface observed initially were still present at six months post-implantation. Implantation of PRECLUDE Dura Substitute, a nonabsorbable material comprised of expanded polytetrafluoroethylene, resulted in virtually no early reaction, and few adhesions to the brain surface at any time period. Although this material was eventually incorporated by fibrosis, islands of osseous metaplasia were also observed in this 'replacement' dura mater. The tissue reaction to Codman ETHISORB Dura Patch, an absorbable material comprised of polyglactin 910 and polydioxanone, was generally characterized by low-grade granulomatous inflammation and initial adhesions to the brain surface. The three-dimensional structure of this implant acted as a scaffold to guide the development and integration of a 'replacement' dura mater. The absorption of the material was associated with complete resolution of the inflammatory reaction, a lack of cerebral adhesions, and restoration of the normal architecture of this region. In conclusion, subdural implantation of Dura-Guard Dural Repair Patch, PRECLUDE Dura Substitute, or Codman ETHISORB Dura Patch in rabbits for up to six months resulted in the eventual restoration of the dura mater without significant adverse effects. However, osseous metaplasia associated with nonabsorbable Dura-Guard Dural Repair Patch and PRECLUDE Dura Substitute, and the infiltration of Dura-Guard Dural Repair Patch by fibrosis suggests that long-term follow-up may be needed after the use of these materials in patients. An advantage of Codman ETHISORB Dura Patch was that it was completely absorbed after guiding the restoration of the dura mater without any morphological sequelae.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 50 条
  • [21] Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model
    Hernandez, Angela-Patricia
    Micaelo, Ania
    Pinol, Rafael
    Garcia-Vaquero, Marina L.
    Aramayona, Jose J.
    Criado, Julio J.
    Rodriguez, Emilio
    Ignacio Sanchez-Gallego, Jose
    Landeira-Vinuela, Alicia
    Juanes-Velasco, Pablo
    Diez, Paula
    Gongora, Rafael
    Jara-Acevedo, Ricardo
    Orfao, Alberto
    Miana-Mena, Javier
    Munoz, Maria Jesus
    Villanueva, Sergio
    Millan, Angel
    Fuentes, Manuel
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [22] USE OF AN ANIMAL-MODEL FOR GENETIC EVALUATION OF THE LACAUNE DAIRY SHEEP
    BARILLET, F
    BOICHARD, D
    BARBAT, A
    ASTRUC, JM
    BONAITI, B
    LIVESTOCK PRODUCTION SCIENCE, 1992, 31 (3-4): : 287 - 299
  • [23] ANIMAL-MODEL EVALUATION WITHIN HERD LINKED TO NATIONAL EVALUATIONS
    WIGGANS, GR
    VANRADEN, PM
    JOURNAL OF DAIRY SCIENCE, 1990, 73 (07) : 1956 - 1963
  • [24] Animal model versus conventional methods of sire evaluation in sahiwal cattle
    Banik, S.
    Gandhi, R. S.
    ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2006, 19 (09): : 1225 - 1228
  • [25] HYDRALAZINE PHARMACOKINETICS AND INTERACTION WITH FOOD - AN EVALUATION OF THE DOG AS AN ANIMAL-MODEL
    SEMPLE, HA
    TAM, YK
    COUTTS, RT
    PHARMACEUTICAL RESEARCH, 1990, 7 (03) : 274 - 279
  • [26] Grading versus animal model evaluation in arctic fox (Alopex lagopus)
    Wierzbicki, H
    Filistowicz, A
    CZECH JOURNAL OF ANIMAL SCIENCE, 2001, 46 (06) : 252 - 259
  • [27] Evaluation of the Suitability of Miniature Pigs as an Animal Model of Juvenile Osteochondritis Dissecans
    Toth, Ferenc
    Johnson, Casey P.
    Mills, Benigno
    Nissi, Mikko J.
    Nykaenen, Olli
    Ellermann, Jutta
    Ludwig, Kai D.
    Tompkins, Marc
    Carlson, Cathy S.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2019, 37 (10) : 2130 - 2137
  • [28] Unilateral pleural effusion in an animal model: Evaluation of lung function with EBCT
    Recheis, W
    Pallwein, L
    Soegner, P
    Faschingbauer, R
    Schmidbauer, G
    Kleinsasser, A
    Loeckinger, A
    Hoermann, C
    zur Nedden, D
    MEDICAL IMAGING 2003: PHYSIOLOGY AND FUNCTION: METHODS, SYSTEMS, AND APPLICATIONS, 2003, 5031 : 459 - 467
  • [29] Definition of season in animal model evaluation of Nili-Ravi buffaloes
    Khan, MS
    Bhatti, SA
    Asghar, AA
    Chaudhary, MA
    Bilal, MQ
    ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 1997, 10 (01): : 70 - 74
  • [30] Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety
    Jimenez-Gomez, Corina
    Osentoski, Andrew
    Woods, James H.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 (07): : 711 - 713